AGRANULOCYTOSIS: IN A PATIENT TREATED WITH CARBIMAZOLE
- 20 February 1954
- journal article
- Published by Elsevier in The Lancet
- Vol. 263 (6808) , 396
- https://doi.org/10.1016/s0140-6736(54)90931-9
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- TREATMENT OF THYROTOXICOSIS WITH 'NEO MERCAZOLE' (2-CARBETHOXYTHIO-1-METHYLGLYOXALINE): REPORT OF 120 CASESThe Lancet, 1953
- THYROTOXICOSIS TREATED WITH 2-CARBETHOXYTHIO-1-METHYLGLYOXALINE (' NEO MERCAZOLE ')The Lancet, 1953
- HYPERTHYROIDISM—AN EVALUATION OF TREATMENT WITH ANTITHYROID DRUGS FOLLOWED BY SUBTOTAL THYROIDECTOMYAnnals of Internal Medicine, 1952
- AGRANULOCYTOSIS OCCURRING DURING METHIMAZOLE ("TAPAZOLE") THERAPYJAMA, 1952
- TREATMENT OF THYROTOXICOSIS WITH 2-CARBETHOXYTHIO-1-METHYLGLYOXALINE (C.G.1)The Lancet, 1951
- ANTITHYROID ACTIVITY OF 2-CARBETHOXYTHIO- 1-METHYLGLYOXALINEThe Lancet, 1951